Alteplase 2.2 mg / 2mL Injection 2 mL (Cathflo Activase)
Comprehensive product details for sourcing and verification.
| NDC 11 | 50242-0041-64 |
|---|---|
| Product NDC | 50242-0041 |
| Generic Drug Name | Alteplase |
| Brand Name | Cathflo Activase |
| Manufacturer | Genentech, Inc. |
| Strength | 2.2 mg / 2mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 1 Vial |
| Package Description | 1 VIAL in 1 CARTON (50242-041-64) / 2 mL in 1 VIAL |
| Active Ingredients | Alteplase |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Alteplase 2.2 mg / 2mL Injection is tracked under NDC 50242-0041-64 and rolls up into product family 50242-0041. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 1 Vial.
- Manufacturer: Genentech, Inc..
- Dosage form: Injection.
- Family size: 2 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Documented shortage history shows alteplase shortage listings recurring across 2021 through 2024, which suggests elevated future supply risk for this product.
Drug Shortage Index family
View Alteplase in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Alteplase.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Alteplase 2.2 mg / 2mL Injection 2 mL (Cathflo Activase), NDC 50242-0041-64, is a Genentech, Inc. 2.2 mg / 2mL injection presentation packaged as 1 Vial. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 50242-0041-64.
- Digits-only NDC 11: 50242004164.
- Possible 10-digit display format: 50242-041-64 (5024204164).
Helpful product links
- Search by brand name: Cathflo Activase.
- Exact NDC 11: 50242-0041-64.
- Product family NDC: 50242-0041.
- Other package sizes in this family: 10 Vial.
- Compare related presentations: Alteplase 2.2 mg / 2mL Injection 2 mL (Cathflo Activase).
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.